Free Trial

Fresenius Medical Care (FMS) Competitors

Fresenius Medical Care logo
$29.30 -0.50 (-1.67%)
Closing price 03:59 PM Eastern
Extended Trading
$29.70 +0.39 (+1.34%)
As of 05:17 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FMS vs. NTRA, HIMS, OPCH, GH, RDNT, BTSG, SHC, PRVA, SGRY, and CON

Should you be buying Fresenius Medical Care stock or one of its competitors? The main competitors of Fresenius Medical Care include Natera (NTRA), Hims & Hers Health (HIMS), Option Care Health (OPCH), Guardant Health (GH), RadNet (RDNT), BrightSpring Health Services (BTSG), Sotera Health (SHC), Privia Health Group (PRVA), Surgery Partners (SGRY), and Concentra Group Holdings Parent (CON). These companies are all part of the "healthcare" industry.

Fresenius Medical Care vs.

Natera (NASDAQ:NTRA) and Fresenius Medical Care (NYSE:FMS) are both large-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their analyst recommendations, risk, community ranking, earnings, profitability, dividends, valuation, institutional ownership and media sentiment.

Natera has a beta of 1.79, indicating that its share price is 79% more volatile than the S&P 500. Comparatively, Fresenius Medical Care has a beta of 0.85, indicating that its share price is 15% less volatile than the S&P 500.

Natera presently has a consensus price target of $182.12, indicating a potential upside of 19.44%. Fresenius Medical Care has a consensus price target of $27.80, indicating a potential downside of 5.13%. Given Natera's stronger consensus rating and higher probable upside, equities research analysts plainly believe Natera is more favorable than Fresenius Medical Care.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Natera
0 Sell rating(s)
0 Hold rating(s)
16 Buy rating(s)
0 Strong Buy rating(s)
3.00
Fresenius Medical Care
1 Sell rating(s)
2 Hold rating(s)
1 Buy rating(s)
0 Strong Buy rating(s)
2.00

Fresenius Medical Care has a net margin of 3.43% compared to Natera's net margin of -14.01%. Fresenius Medical Care's return on equity of 6.04% beat Natera's return on equity.

Company Net Margins Return on Equity Return on Assets
Natera-14.01% -26.23% -14.27%
Fresenius Medical Care 3.43%6.04%2.69%

In the previous week, Natera had 17 more articles in the media than Fresenius Medical Care. MarketBeat recorded 24 mentions for Natera and 7 mentions for Fresenius Medical Care. Natera's average media sentiment score of 1.53 beat Fresenius Medical Care's score of 1.43 indicating that Natera is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Natera
21 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Very Positive
Fresenius Medical Care
6 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

99.9% of Natera shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care shares are held by institutional investors. 7.6% of Natera shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Natera received 70 more outperform votes than Fresenius Medical Care when rated by MarketBeat users. Likewise, 68.90% of users gave Natera an outperform vote while only 54.64% of users gave Fresenius Medical Care an outperform vote.

CompanyUnderperformOutperform
NateraOutperform Votes
494
68.90%
Underperform Votes
223
31.10%
Fresenius Medical CareOutperform Votes
424
54.64%
Underperform Votes
352
45.36%

Fresenius Medical Care has higher revenue and earnings than Natera. Natera is trading at a lower price-to-earnings ratio than Fresenius Medical Care, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Natera$1.83B11.37-$434.80M-$1.47-103.73
Fresenius Medical Care$19.49B0.88$540.07M$1.1226.16

Summary

Natera beats Fresenius Medical Care on 11 of the 18 factors compared between the two stocks.

Get Fresenius Medical Care News Delivered to You Automatically

Sign up to receive the latest news and ratings for FMS and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

FMS vs. The Competition

MetricFresenius Medical Carehealth & allied services, not elsewhere classified IndustryMedical SectorNYSE Exchange
Market Cap$17.20B$2.03B$5.33B$19.30B
Dividend Yield1.49%6.96%5.21%3.84%
P/E Ratio24.2215.8626.7134.53
Price / Sales0.883.54386.1334.83
Price / Cash4.969.3238.2517.51
Price / Book1.073.926.774.69
Net Income$540.07M$87.49M$3.23B$1.02B
7 Day Performance3.11%-4.16%1.80%-1.74%
1 Month Performance22.13%-4.62%11.10%7.50%
1 Year Performance40.51%-28.95%17.11%4.15%

Fresenius Medical Care Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FMS
Fresenius Medical Care
3.1161 of 5 stars
$29.30
-1.7%
$27.80
-5.1%
+39.1%$17.20B$19.49B24.22123,200News Coverage
Positive News
Analyst Forecast
NTRA
Natera
3.2706 of 5 stars
$157.02
+3.3%
$181.82
+15.8%
+39.6%$21.19B$1.83B-89.053,020Positive News
HIMS
Hims & Hers Health
2.3475 of 5 stars
$55.26
+6.4%
$37.67
-31.8%
+229.9%$12.35B$1.78B125.40650Trending News
Analyst Upgrade
Insider Trade
Gap Down
High Trading Volume
OPCH
Option Care Health
4.2152 of 5 stars
$31.84
0.0%
$35.50
+11.5%
+12.3%$5.19B$5.19B26.655,600Positive News
GH
Guardant Health
4.6454 of 5 stars
$41.71
0.0%
$52.32
+25.4%
+57.4%$5.14B$774.00M-11.671,790Positive News
RDNT
RadNet
3.3748 of 5 stars
$57.03
+2.3%
$69.75
+22.3%
-0.3%$4.28B$1.83B-815.178,970News Coverage
Analyst Downgrade
BTSG
BrightSpring Health Services
1.6401 of 5 stars
$22.36
-2.0%
$22.89
+2.4%
+112.9%$3.86B$11.86B-85.2335,000Positive News
SHC
Sotera Health
2.9335 of 5 stars
$13.50
+2.8%
$15.80
+17.1%
+13.3%$3.83B$1.11B53.933,000Positive News
PRVA
Privia Health Group
3.574 of 5 stars
$25.11
+0.3%
$27.38
+9.1%
+47.4%$3.05B$1.80B251.37810Positive News
SGRY
Surgery Partners
2.7923 of 5 stars
$23.27
+5.0%
$34.75
+49.3%
-10.7%$2.97B$3.11B-48.3312,200
CON
Concentra Group Holdings Parent
N/A$21.67
+1.3%
$28.50
+31.5%
N/A$2.76B$1.90B16.1711,000Positive News

Related Companies and Tools


This page (NYSE:FMS) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners